A Review of the Clinical Effectiveness and Safety of Hybrid Cooperative Complexes in Intra-articular Viscosupplementation Marcin DomżalskiAlberto Migliore Review Open access 03 May 2022 Pages: 957 - 974
Real-World Effectiveness of Belimumab in Systemic Lupus Erythematosus: A Systematic Literature Review Shirley P. HuangSonya J. SnedecorChristopher F. Bell Review Open access 21 May 2022 Pages: 975 - 991
COVID-19 Outcomes and Vaccination in Patients with Spondyloarthritis Atul DeodharSuleman BhanaLianne S. Gensler Review Open access 22 May 2022 Pages: 993 - 1016
Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2) Georg SchettMatthew J. LozaKristen Sweet Original Research Open access 30 March 2022 Pages: 1017 - 1030
Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry Manuel José Moreno-RamosCarlos Sanchez-PiedraIsabel Castrejón Original Research Open access 25 April 2022 Pages: 1031 - 1047
Abnormalities of Peripheral Lymphocyte Subsets in Rheumatoid Arthritis Patients Complicated with Osteoporosis Ting ChengSheng-Xiao ZhangXiao-Feng Li Original Research Open access 02 May 2022 Pages: 1049 - 1059
Associations of Healthcare Utilization and Costs with Increasing Pain and Treatment Intensity Levels in Osteoarthritis Patients: An 18-Year Retrospective Study Jove GrahamTonia NovosatPatricia Dorling Original Research Open access 10 May 2022 Pages: 1061 - 1078
Exploring the Association Between History of Psoriasis (PSO) and Disease Activity in Patients with Psoriatic Arthritis (PsA) Shan-Shan LiNa DuTian-Fang Li Original Research Open access 17 May 2022 Pages: 1079 - 1090
Diabetes-Related Complications and Costs in Medicare Beneficiaries with Comorbid Rheumatoid Arthritis and Diabetes Treated with Abatacept Versus Other Targeted DMARDs Vardhaman PatelZulkarnain PulunganKaleb Michaud Original Research Open access 23 May 2022 Pages: 1091 - 1107
The Non-medical Switch from Reference Adalimumab to Biosimilar Adalimumab is Highly Successful in a Large Cohort of Patients with Stable Inflammatory Rheumatic Joint Diseases: A Real-Life Observational Study Roxanne C. S. van AdrichemHanneke J. E. VoorneveldRadjesh J. Bisoendial Original Research Open access 03 June 2022 Pages: 1109 - 1118
Health Economic Evaluation of a High and Low Molecular Weight Hyaluronic Acid Formulation for the Treatment of Knee Osteoarthritis. Post Hoc Analyses from a Randomized Clinical Trial Olivier BruyèreJean-Yves ReginsterGermain Honvo Original Research Open access 03 June 2022 Pages: 1119 - 1128
Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Secukinumab Uta KiltzPetros P. SfikakisPiotr Jagiello Original Research Open access 08 June 2022 Pages: 1129 - 1142
Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry Min Jung KimSun-Kyung LeeKichul Shin Original Research Open access 18 June 2022 Pages: 1143 - 1155
A Randomized Pharmacokinetic Study in Healthy Male Subjects Comparing a High-concentration, Citrate-free SB5 Formulation (40 mg/0.4 ml) and Prior SB5 (Adalimumab Biosimilar) So-shin AhnMinkyung LeeSukho Lee Original Research Open access 01 July 2022 Pages: 1157 - 1169
Association between TNFi anti-drug antibodies, smoking, and disease activity in patients with inflammatory arthritis: Results from a Norwegian cross-sectional observational study Brigitte MichelsenKristine Thomassen BergetGlenn Haugeberg Brief Report Open access 20 May 2022 Pages: 1171 - 1179
Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 Trials Philip MeaseArthur KavanaughLaure Gossec Brief Report Open access 23 May 2022 Pages: 1181 - 1191
Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort Fabio Massimo PerrottaSilvia ScriffignanoEnnio Lubrano Brief Report Open access 25 May 2022 Pages: 1193 - 1201
Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study Silvia ScriffignanoFabio Massimo PerrottaEnnio Lubrano Brief Report Open access 17 June 2022 Pages: 1203 - 1211
Plasma Exchange in a Patient with Immune Thrombocytopenia Associated with Antiphospholipid Syndrome Hospitalized for COVID-19 Federico BoggioAlessandro CiavarellaFlora Peyvandi Case Report Open access 15 June 2022 Pages: 1213 - 1219
Letter to the Editor Regarding “Ultrasound Features of Adhesive Capsulitis” Mathieu Boudier-RevéretMing-Yen HsiaoMin Cheol Chang Letter to the Editor Open access 05 May 2022 Pages: 1221 - 1223
A Response to: Letter to the Editor Regarding Ultrasound Features of Adhesive Capsulitis Salvatore Massimo StellaRoberta GualtierottiStefano Galletti Letter to the Editor Open access 14 May 2022 Pages: 1225 - 1228
Letter to the Editor Regarding “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?” Josef Finsterer Letter Open access 13 June 2022 Pages: 1229 - 1231
A Response to: Letter to the Editor Regarding the Article: “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?” Alexandros A. DrososEleftherios PelechasParaskevi V. Voulgari Letter Open access 27 May 2022 Pages: 1233 - 1235
Letter to the Editor Regarding Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind David Bernal-BelloDavid Serantes-GómezBegoña Frutos-Pérez Letter Open access 18 June 2022 Pages: 1237 - 1240
A Response to: Letter to the Editor Regarding [Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind] Bo LiJunqing YanXuan Wang Letter Open access 18 June 2022 Pages: 1241 - 1243
Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study) Blanca Hernández-CruzJosé RosasMercedes Núñez Correction Open access 02 June 2022 Pages: 1245 - 1246
Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2) Georg SchettMatthew J. LozaKristen Sweet Publisher Correction Open access 02 July 2022 Pages: 1247 - 1248
